H1B Report
Side-by-side comparison

Weill Cornell Medical College vs WIPRO LIMITED

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
Weill Cornell Medical College
NYRank #FEIN 13-1623978
Entity B
WIPRO LIMITED
NJRank #6FEIN 98-0154401

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricWeill Cornell Medical CollegeWIPRO LIMITED
Total filings2,04672,392
Certified %72.92%91.61%
Denied %0.20%0.37%
Withdrawn %2.64%1.37%
Cert-withdrawn %24.24%6.64%
Rank#6
Active yearsFY2010–FY2026FY2010–FY2026
Worksite stateNYNJ

Outcomes — Weill Cornell Medical College

DOL case-status mix.

Outcome breakdown: Certified 72.9%, Cert-withdrawn 24.2%, Withdrawn 2.6%, Denied 0.2%
Outcome breakdown
OutcomeShare
Certified72.9%
Cert-withdrawn24.2%
Withdrawn2.6%
Denied0.2%
Certified72.9%
Cert-withdrawn24.2%
Withdrawn2.6%
Denied0.2%

Outcomes — WIPRO LIMITED

DOL case-status mix.

Outcome breakdown: Certified 91.6%, Cert-withdrawn 6.6%, Withdrawn 1.4%, Denied 0.4%
Outcome breakdown
OutcomeShare
Certified91.6%
Cert-withdrawn6.6%
Withdrawn1.4%
Denied0.4%
Certified91.6%
Cert-withdrawn6.6%
Withdrawn1.4%
Denied0.4%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

Weill Cornell Medical College
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY2010118
FY2011105
FY2012129
FY2013131
FY2014131
FY2015123
FY2016134
FY2017151
FY2018153
FY2019136
FY202011
FY202122
FY202214
FY2023156
FY2024213
FY2025173
FY2026146
WIPRO LIMITED
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20103,039
FY20113,025
FY20127,031
FY20136,574
FY20148,104
FY201511,824
FY201610,254
FY20175,012
FY20186,067
FY20194,154
FY202094
FY2021128
FY202297
FY2023554
FY20242,296
FY20252,289
FY20261,850

Top 5 occupations — WIPRO LIMITED

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.